Updated estimates of neural tube defects prevented by mandatory folic Acid fortification - United States, 1995-2011 - PubMed (original) (raw)

Updated estimates of neural tube defects prevented by mandatory folic Acid fortification - United States, 1995-2011

Jennifer Williams et al. MMWR Morb Mortal Wkly Rep. 2015.

Abstract

In 1992, the U.S. Public Health Service recommended that all women capable of becoming pregnant consume 400 µg of folic acid daily to prevent neural tube defects (NTDs). NTDs are major birth defects of the brain and spine that occur early in pregnancy as a result of improper closure of the embryonic neural tube, which can lead to death or varying degrees of disability. The two most common NTDs are anencephaly and spina bifida. Beginning in 1998, the United States mandated fortification of enriched cereal grain products with 140 µg of folic acid per 100 g. Immediately after mandatory fortification, the birth prevalence of NTD cases declined. Fortification was estimated to avert approximately 1,000 NTD-affected pregnancies annually. To provide updated estimates of the birth prevalence of NTDs in the period after introduction of mandatory folic acid fortification (i.e., the post-fortification period), data from 19 population-based birth defects surveillance programs in the United States, covering the years 1999-2011, were examined. After the initial decrease, NTD birth prevalence during the post-fortification period has remained relatively stable. The number of births occurring annually without NTDs that would otherwise have been affected is approximately 1,326 (95% confidence interval = 1,122-1,531). Mandatory folic acid fortification remains an effective public health intervention. There remain opportunities for prevention among women with lower folic acid intakes, especially among Hispanic women, to further reduce the prevalence of NTDs in the United States.

PubMed Disclaimer

Figures

FIGURE

FIGURE

Prevalence of neural tube defects (NTDs) (anencephaly and spina bifida) before and after mandatory folic acid fortification, by maternal race/ethnicity — 19 population-based birth defects surveillance programs,* United States, 1995–2011 * Contributing programs are based in Arkansas, Arizona, California, Colorado, Georgia, Illinois, Iowa, Kentucky, Maryland, New Jersey, New York, North Carolina, Oklahoma, Puerto Rico, South Carolina, Texas, Utah, West Virginia, and Wisconsin. † 95% confidence interval.

Similar articles

Cited by

References

    1. CDC. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recomm Rep. 1992;41(RR-14) - PubMed
    1. CDC. CDC Grand Rounds: additional opportunities to prevent neural tube defects with folic acid fortification. MMWR Morbid Mortal Wkly Rep. 2010;59:980–4. - PubMed
    1. CDC. Spina bifida and anencephaly before and after folic acid mandate—United States, 1995–1996 and 1999–2000. MMWR Morbid Mortal Wkly Rep. 2004;53:362–5. - PubMed
    1. Grosse SD, Ouyang L, Collins JS, Green D, Dean JH, Stevenson RE. Economic evaluation of a neural tube defect recurrence-prevention program. Am J Prev Med. 2008;35:572–7. - PubMed
    1. Pfeiffer CM, Hughes JP, Lacher DA, et al. Estimation of trends in serum and RBC folate in the United States population from pre- to post-fortification using assay-adjusted data from the NHANES 1988–2010. J Nutr. 2012;142:886–93. - PMC - PubMed

MeSH terms

Substances

LinkOut - more resources